Allergic reactions eg, angioedema, anaphylaxis. Stevens-Johnson syndrome, toxic epidermal necrolysis, & drug reaction w/ eosinophilia & systemic symptoms (DRESS). Severe renal impairment (GFR <10 mL/min), significant hepatic disease. Concomitant use w/ ergot derivatives. Superinfection may occur. Clostridium difficile
-associated diarrhoea. Prolonged cardiac repolarization & QT interval in patients at risk of cardiac arrhythmia & Torsades de pointes. Congenital or documented QT prolongation, receiving treatment w/ other active substances known to prolong QT interval eg, antiarrhythmics of class IA & III, antipsychotic agents, antidepressants & fluoroquinolones. Electrolyte disturbance eg, hypokalaemia & hypomagnaesemia; bradycardia, cardiac arrhythmia or insufficiency. Oral susp
Diabetes, fructose intolerance, glucose-galactose malabsorption or saccharase-isomaltase deficiency due to sucrose content. Inj
Do not administer as IV bolus or IM. Childn (inj). Pregnancy & lactation. Elderly.